Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular weight heparin being developed with Elan Corporation for treatment of ulcerative colitis.


Contact Details:
Post Office Box 14287, Research Triangle Park
NC
27709
United States of America
Tel:919-558-8688
Fax:919-558-8686
Email:info@incara.com.
WWW:

www.intercardia.com/




BioNews Results for Incara Pharmaceuticals:

Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer
FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu
Washington Business Journal:  Nov 16 2009 1:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu
St Louis Business Journal:  Nov 16 2009 12:45AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu
San Jose Business Journal:  Nov 16 2009 12:35AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu
Reuters:  Nov 16 2009 12:43AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Incara Pharmaceuticals news.

Incara Pharmaceuticals Clinical Trials:

Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1004 times since April 2007, the link to the organisation's website has been followed 196 times

Recent Search Terms used to find this page: Incara Pharmaceuticals | Incara Pharmaceuticals | ncara | incara | incara pharmaceuticals | Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. | Incara Pharmaceuticals Inc. | incara pharmaceuticals | incara pharmaceuticals | incara | .



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Incara Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.